These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7500613

  • 1. Evaluation of the Abbott TDx serum benzodiazepine immunoassay for the analysis of lorazepam, adinazolam, and N-desmethyladinazolam.
    Fraser AD, Bryan W.
    J Anal Toxicol; 1995 Sep; 19(5):281-4. PubMed ID: 7500613
    [Abstract] [Full Text] [Related]

  • 2. Urinary screening for adinazolam and its major metabolites by the Emit d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC.
    Fraser AD, Isner AF, Bryan W.
    J Anal Toxicol; 1993 Sep; 17(7):427-31. PubMed ID: 8309217
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the Abbott ADx and TDx serum benzodiazepine immunoassays for analysis of alprazolam.
    Fraser AD, Bryan W.
    J Anal Toxicol; 1991 Sep; 15(2):63-5. PubMed ID: 1675703
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteers.
    Fleishaker JC, Hulst LK, Ekernäs SA, Grahnén A.
    J Clin Psychopharmacol; 1992 Dec; 12(6):403-14. PubMed ID: 1474178
    [Abstract] [Full Text] [Related]

  • 6. Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humans.
    Golden PL, Warner PE, Fleishaker JC, Jewell RC, Millikin S, Lyon J, Brouwer KL.
    Clin Pharmacol Ther; 1994 Aug; 56(2):133-41. PubMed ID: 8062489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteers.
    Fleishaker JC, Friedman H, Pollock SR, Smith TC.
    Clin Pharmacol Ther; 1990 Dec; 48(6):652-64. PubMed ID: 2249377
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
    Charlier CJ, Plomteux GJ.
    Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
    [Abstract] [Full Text] [Related]

  • 14. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood.
    Huang W, Moody DE.
    J Anal Toxicol; 1995 Oct; 19(6):333-42. PubMed ID: 8926726
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
    Meatherall R.
    J Anal Toxicol; 1994 Oct; 18(7):385-90. PubMed ID: 7861751
    [Abstract] [Full Text] [Related]

  • 17. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD, Howell P.
    J Anal Toxicol; 1998 Oct; 22(1):50-4. PubMed ID: 9491969
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Abbott propoxyphene assay: evaluation and comparison of TDx FPIA and GC/MS methods.
    Kintz P, Mangin P.
    J Anal Toxicol; 1993 Oct; 17(4):222-4. PubMed ID: 8371551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.